Gender differences in the pharmacology of nicotine addiction
Tóm tắt
Smoking rates have declined in recent years less rapidly in women than in men. More adolescent girls than boys are currently smoking. Quitting smoking is reported in many studies to be more difficult in women than in men. These observations suggest that there may be gender differences in the nature of nicotine addiction. Gender differences in various pharmacological processes involved in nicotine addiction are reviewed. Women take in less nicotine from smoking per cigarette than men but, because of slower metabolism, nicotine levels in the body for a given number of cigarettes per day are similar in male and female smokers. Women tend to be less sensitive to the discriminative effects of nicotine and tend to regulate nicotine intake less precisely than men. On the other hand, women appear to be more sensitive to the effects of nicotine in reducing negative affect and reducing body weight. There is a strong association between depression and smoking, and this association appears to be stronger in women than in men. Women tend to respond more to environmental cues associated with smoking than do men. Thus, several lines of evidence suggest that nicotine addiction is different in women than in men. Understanding the basis for gender differences may be of utility in individualizing and optimizing smoking cessation therapy.
Từ khóa
Tài liệu tham khảo
Fiore MC, 1989, Trends in cigarette smoking in the United States. The changing influence of gender and race, J Am Med Assoc, 261, 49, 10.1001/jama.1989.03420010059033
Department of Health and Human Services PHS., 1988, The health consequences of smoking: nicotine addiction
Henningfield JE, 1995, Psychopharmacology: the fourth generation of progress, 1715
LeHouezec J, 1991, Basic and clinical psychopharmacology of nicotine, Clin Chest Med, 12, 681, 10.1016/S0272-5231(21)00817-0
Benowitz NL., 1990, Research findings on smoking of abused substances, NIDA Research Monograph 99, 12
Benowitz NL, 1990, Nicotine psychopharmacology: molecular, cellular and behavioral aspects, 112, 10.1093/oso/9780192616142.003.0004
Rosecrans JA, 1972, Brain area nicotine levels in male and female rats of two strains, Arch Int Pharmacodynamie, 196, 46
Benowitz NL, 1994, Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine, J Pharmacol Exp Ther, 268, 296
Benowitz NL, 1985, Nicotine renal excretion rate influences nicotine intake during cigarette smoking, J Pharmacol Exp Ther, 234, 153
Byrd GD, 1992, Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans‐3′‐hydroxycotinine in smokers, Drug Metab Disp, 20, 192
Kyerematen GA, 1988, Sexual dimorphism of nicotine metabolism and distribution in the rat. Studies in vivo and in vitro, Drug Metab Disp, 16, 823
Seaton M, 1991, Nicotine metabolism in stumptailed macaques, Macaca arctoides, Drug Metab Disp, 19, 946
Jenner P, 1973, Comparative in vitro hepatic metabolism of some tertiary N‐methyl tobacco alkaloids in various species, Res commun Clin Pathol Pharmacol, 6, 829
Moody PM., 1980, The relationships of quantified human smoking behavior and demographic variables, Soc Sci Med, 14, 49
Clarke PBS, 1985, Nicotinic binding in rat brain: autoradiographic comparison of [[sup 3]H] acetylcholine, [3H]nicotine and [[sup 125]I] abungarotoxin, J Neurosci, 5, 1307, 10.1523/JNEUROSCI.05-05-01307.1985
Collins AC, 1994, Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion, J Pharmacol Exp Ther, 271, 125
Breese CR, 1997, Effect of smoking history of [[sup 3]H]nicotine binding in human postmortem brain, J Pharmacol Exp Ther, 282, 7
Perkins KA., 1996, Sex differences in nicotine versus non‐nicotine reinforcement as determinants of tobacco smoking, Exp Clin Psychopharmacol, 4, 166, 10.1037/1064-1297.4.2.166
Perkins KA, 1995, Problems of drug dependence, 288
Henningfield JE, 1987, Brain reward systems and abuse, 147
Henningfield JE, 1985, Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine, J Pharmacol Exp Ther, 234, 1
Perkins KA, 1994, Chronic and acute tolerance to subjective, behavioral and cardiovascular effects of nicotine in humans, J Pharmacol Exp Ther, 270, 628
Solomon LJ, 1993, Nicotine addiction principles and management, 339, 10.1093/oso/9780195064414.003.0017
Perkins KA, 1994, Acute thermogenic effects of nicotine combined with caffeine during light physical activity in male and female smokers, Am J Clin Nutr, 60, 312, 10.1093/ajcn/60.3.312
Porchet HC, 1988, Pharmacodynamic model of tolerance: application to nicotine, J Pharmacol Exp Ther, 244, 231
Fattinger K, 1997, Pharmacodynamics of acute tolerance to multiple nicotinic effects in humans, J Pharmacol Exp Ther, 281, 1238
Department of Health and Human Services PHS., 1990, The health benefits of smoking cessation. A report of the Surgeon General
American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders (DSM‐IV)
Shiffman SM., 1979, National institute on drug abuse monograph
Guilford JS., 1967, Studies and issues in smoking behavior, 95
Repsher LH., 1994, Smoking cessation by women and older persons: results from the Transdermal Nicotine Study Group, Modern Med, 62, 34
Allen SS, 1991, The shortened premenstrual assessment form, J Reprod Med, 36, 769
American Psychiatric Association, 1987, Diagnostic and statistical manual of mental disorders
Hall SM, 1993, Nicotine, negative affect and depression, J Consult Clin Psychol, 61, 761, 10.1037/0022-006X.61.5.761
Wilder A., 1965, Narcotics, 85
Rickard‐Figneroa K, 1985, Assessment of smoking urge and its concomitants under an environmental smoking cue manipulation, Addict Behav, 10, 246